RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @BAwsare: The EOLIA trial and defense of ECMO by Gattinoni. EOLIA points out ECMO is essential for severe ARDS. Best when single organ f…
RT @crdc2001: ECMO in ARDS by EOLIA: https://t.co/ID9eZbOzzT
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @HerxxAU: ‘taking the cross-over rate into account, and considering that the survival rate of the crossed-over patients without ECMO wou…
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @HerxxAU: ‘taking the cross-over rate into account, and considering that the survival rate of the crossed-over patients without ECMO wou…
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
ECMO in ARDS by EOLIA: https://t.co/ID9eZbOzzT
The EOLIA trial and defense of ECMO by Gattinoni. EOLIA points out ECMO is essential for severe ARDS. Best when single organ failure https://t.co/ZfwGOXoS2q
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @HerxxAU: ‘taking the cross-over rate into account, and considering that the survival rate of the crossed-over patients without ECMO wou…
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
‘taking the cross-over rate into account, and considering that the survival rate of the crossed-over patients without ECMO would have been between 0 and 33%, one finds a significant increase in relative risk reduction with ECMO (from 0.74 to 0.62, p < 0
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
RT @dr_mark_russell: Another editorial/review of EOLIA #PedsICU #ECLS #ECMO https://t.co/kjUwY8ivSm
RT @Crit_Care: Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
Another editorial/review of EOLIA #PedsICU #ECLS #ECMO https://t.co/kjUwY8ivSm
Use of ECMO in ARDS: does the EOLIA trial really help? @gattinon #FOAMed https://t.co/7r4HxW6aq6
Use of ECMO in ARDS: does the EOLIA trial really help? https://t.co/aJIN8mzpzU #
Excellent arguments made RE the interpretation of EOLIA- this is a quick and must read https://t.co/9fI4nTt2HZ
RT @succenyl: if we devided HCWs to ECLS believers and non believers, 1st group to whom i am will get the strong positive signals from the…
RT @ecmokolkata: Will the EOLIA trial change our perspective of ECMO in severe ARDS? Statistics are an operational tool and not a religion;…
Will the EOLIA trial change our perspective of ECMO in severe ARDS? Statistics are an operational tool and not a religion; the knowledge, skill, and common sense of physicians are the values in the balance with “0.05”. https://t.co/WknHgGar1d
if we devided HCWs to ECLS believers and non believers, 1st group to whom i am will get the strong positive signals from the trial and care about 11% absolute mortality reduction while those are non believers will care for the stupid 0.07 p vaue https://
Use of #ECMO in #ARDS: does the EOLIA trial really help? closer con- siderations about results & rationale/feasibility/utility of VV extracorporeal support trials, @Crit_Care open access editorial by @gattinon #FOAMcc https://t.co/fgfqmXjr0S